| cGMP (pmol/mg protein) |
---|
 | Intact | Denuded |
l-NAME 50 μM | MB 10 μM | Ca2+free medium |
---|
Control | 0.53 ± 0.08 | – | – | – | – |
SNP 10 μM | 3.45 ± 0.56* | – | – | – | – |
ACh 10 μM | 3.21 ± 0.42* | 0.60 ± 0.18 | 0.70 ± 0.09 | 0.52 ± 0.12 | 0.45 ± 0.11 |
PV 100 μg/ml | 3.18 ± 0.74* | 0.57 ± 0.13 | 0.54 ± 0.09 | 0.66 ± 0.07 | 0.64 ± 0.04 |
- After pretreatment with 10 μM IBMX for 5 min, aortic segments were replaced in Ca2+-free Krebs’ (2.5 mM EGTA) buffer or treatment with inhibitors of l-NAME and methylene blue (MB) for 10 min and then sodium nitroprusside (SNP), acetylcholine (ACh) and PV were added for another 2 min. The aortic rings were immersed in liquid nitrogen to stop the reaction. cGMP formation were measured. Data are expressed as the mean ± standard error of the mean (S.E.M) of more than 5 individual experiments. –, not determined. * p < 0.05 indicates a significant difference from the control.